Professional Documents
Culture Documents
Liver Function Tests
Liver Function Tests
The diagnosis can be established noninvasively in the vast majority of patients with abnormal Liver Function Tests.
Appropriate testing can be guided by the pretest probability of specific forms of liver disease
The majority of patients in whom the diagnosis remains unclear after obtaining a history and laboratory testing will have alcoholic liver disease, fatty liver, or NASH
Enzyme tests
Aminotransferases Alkaline phosphatase Gamma glutamyl transpeptidase
Aminotransferases
Alanine aminotransferase (ALT or SGPT), Normal 10-40 IU/L Aspartate aminotransferase (AST or SGOT), Normal 10-40 IU/L
Drug-induced hepatitis
NSAIDS Antibiotics Statins Antiepileptic drugs Antituberculous drugs Acetominophen
Alcoholic Hepatitis AST:ALT ratio > 2 Both levels < 300 GGT elevated 2x normal
Alcoholic Hepatitis
[(Prothrombin time-control) x 4.6] + serum bilirubin = Discriminant Function Value If Discriminant Function Value > 32, mortality of pt > 50% within 2 years Treat with steroids or pentoxyphillin
Hepatitis B
Parenteral drug use Areas of high disease prevalence (Southeast Asia, China and sub-Saharan Africa) Check:
Hepatitis B surface antigen Hepatitis B surface antibody Hepatitis B core antibody
Hepatitis C
Parenteral exposure (blood transfusions, intravenous drug use, occupational) Cocaine use Tattoos High risk sexual behavior.
Hepatitis C
Check Hepatitis C antibody Hepatitis C RNA by PCR
Hemochromatosis
Increased Iron saturation (serum iron/TIBC)
> 45%, obtain serum ferritin
Increased Ferritin (> 400 ng/mL men, > 300 ng/mL in women) Check genetic studies: HFE genetic mutation Liver biopsy
Case 1
Patient is a 42yo female PMH significant only for HTN for which she takes no medications NKDA SH: no tobacco, no illicits, social drinker Works at a drycleaners WBC 7,000 H/H 9/27
Case 1
Case 1
The same patient returns 1 month later with complaint of headaches and fatigue.
Case 2
Patient is an 81yo male admitted secondary to AMI PMH significant for CAD, s/p MI and CHF with EF of 25% Patient had syncopal episode witnessed by nursing
Case 2
AST 19,524, ALT 16,233
Case 3
Patient is a 58yo male Admitted secondary to generalized weakness and vague abdominal pain PMH: none Meds: none NKDA
Case 3
SH: Mild MR. Lives with his brother since the death of his parents. Occasional Etoh and tobacco No environmental exposures
Case 3
Glucose 240 AST 170, ALT 157
Case 4
Patient is a 28yo G2P1001 at 26 weeks EGA presenting to the ED with jaundice PMH: diagnosed with TB 4 weeks prior Meds: INH, Rifampin, Ethambutol, Pyridoxine NKDA
Case 4
SH: Immigrated from Equador 7 months prior, no tobacco, Etoh or illicits BP 128/77, HR 80, R 12, Afebrile ALT 601, AST 319, ALP 251 Tbili 2.7 LDH 246
Autoimmune hepatitis
Autoimmune Hepatitis
Primarily young to middle-aged women Associated with arthralgias, fatigue, anorexia, pruritus Often co-existence of other autoimmune diseases Increased IgG on SPEP Elevated Anti-nuclear antibodies (ANA) & anti-smooth muscle antibodies (SMA)
Wilsons Disease
Genetic disorder of biliary copper excretion Typically age 5-25, but consider the dx in age < 40 Adolescents present with liver disease Adults present with mental status change
Wilsons Disease
Decreased ALP Decreased uric acid Elevated AST and ALT, > 500 IU/L Initial screen: serum ceruloplasmin Opthalmologist for Kayser-Fleischer rings
Intrahepatic Cholestasis
Viral hepatitis Etoh hepatitis EBV Anabolic steroids, Contraceptives CMV TPN Primary biliary sclerosis Primary sclerosing cholangitis
Extrahepatic Cholestasis
Choledocholithiasis Pancreatic or Gallbladder CA Cholangiocarcinoma Primary sclerosing cholangitis Stricture due to chronic pancreatitis AIDS cholangiopathy
Case 5
Patient is 34yo female admitted to the psychiatric ward You are consulted due to elevated liver enzymes on admission labs. Patient with tremor, confusion
Case 5
ALT 1620, AST 1550, ALP22 Na 122 Uric acid 1.1 mg/dL (normal 1.9-7.5mg/dL0
Case 6
58yo female with fatigue and pruritus No significant PMH No medications NKDA
Case 6
ALP 423 Total bilirubin 10.2 AST 110, ALT 133 GGT 55 (normal < 30)
Case 7
60yo female presenting to the ED with jaundice, fatigue and midepigastric ache that radiates to her back. Pain has been present for approximately 4 months, since she was hospitalized for MI 25 lb weight loss
10
Case 7
Glucose 199 AST 156 ALT 144 ALP 155 Total bilirubin 1.1 mg/dL Direct bilirubin 0.3 mg/dL
Case 8
Patient is 38yo female presenting with arthralgias AST 9800, ALT 8600 Total protein 9.0 Albumin 3.5 Total bilirubin 0.7 (normal) ALP 110
Case 9
71yo male with several month history of back pain PMH: CAD s/p CABG 9 years prior, HTN, hypercholesterolemia Meds: ASA, lopressor, lisinopril, pravachol NKDA
Case 9
ALP 772 IU/L Total bilirubin 0.4 mg/dL AST 35 IU/L ALT 28 IU/L GGT 15
11
12
LDH 1-2 = Cardiac, RBC LDH 3 = Pulmonary LDH 4-5 = Muscle, Liver LDH 1 > 2 = MI or hemolytic anemia LDH 5 > 4 = Liver disease (cirrhosis, hepatitis, hepatic congestion)
Review possible link to medications, herbal therapies or recreational drugs Screen for alcohol abuse (screening instruments, AST/ALT ratio >2:1) Obtain serology for hepatitis B and C (HBsAg, HBsAb, HBcAb, HCV Ab) Screen for hemochromatosis (FE/TIBC >45 percent) Evaluate for fatty liver (AST/ALT usually < 1, obtain a RUQ ultrasound)
Exclude muscle disorders (obtain creatinine kinase or aldolase) Obtain thyroid function tests (TSH if hypothyroidism is suspected otherwise obtain a full set of thyroid function tests) Consider celiac disease (especially in patients with a history of diarrhea or unexplained iron deficiency - serum anti endomysial IgA or anti tissue transglutaminase IgA antibodies are reasonable screening tests) Consider adrenal insufficiency
13
Consider autoimmune hepatitis particularly in women and those with a history of other autoimmune disorders (check serum protein electrophoresis, obtain ANA and ASMA if positive) Consider Wilson's disease in those <40 (check ceruloplasmin, evaluate for Kayser Fletcher rings) Consider alpha-1-antitrypsin deficiency especially in patients with a history of emphysema out of proportion to their age or smoking history (obtain alpha-1antitrypsin phenotype)
References
Pratt, DS, Kaplan, MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342:1266. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005 May; 41 (5): 1179-97. American Gastoenterological Association medical position statement: evaluation of liver chemistry tests. Gastroenterology 2002 Oct;123(4):1364-6. Chopra S, Griffin PH: Laboratory tests and diagnostic procedures in evaluation of liver disease. Am J Med 1985;79:221-230. Seth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-145. Pratt DS. Approach to the patient with abnormal liver function tests. UpToDate 2005; volume 11.2.
14